Although cryotherapy and the concept of threshold disease are no longer used clinically, with current standards shifting towards intravitreal anti-VEGF injections and laser photocoagulation, the CRYO-ROP study laid the groundwork for subsequent research and advancements in the treatment of ROP. This evidence concerns the gene VEGFA and retinopathy of prematurity.